Cost-effectiveness of rivaroxaban for the prevention of stroke in patients with non-valvular atrial fibrillation – a multinational study
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.1481
https://www.valueinhealthjournal.com/article/S1098-3015(13)01552-0/fulltext
Section Title :
Cardiovascular Disorders
Section Order :
1045
First Page :
A285
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01552-0&doi=10.1016/j.jval.2013.03.1481